APP and early-onset autosomal dominant Alzheimer disease: FERMT2 has been found to interact with integrins to regulate many physiopathological processes; most notably, FERMT2 has been identified as being associated with amyloid precursor protein (APP) metabolism, which is a significant risk factor for Alzheimer's disease (AD) [65].